An Observational, Prospective, Multicentre Study to Assess the Sensitivity to Change of the SAMANTA Questionnaire in Women With Heavy Menstrual Bleeding (HMB)
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2019
Price : $35 *
At a glance
- Drugs Estradiol valerate/dienogest (Primary) ; Levonorgestrel (Primary) ; Medroxyprogesterone (Primary) ; Hormone replacements
- Indications Menorrhagia
- Focus Therapeutic Use
- Acronyms SAMIRA
- Sponsors Bayer
- 22 Nov 2019 Planned End Date changed from 31 Oct 2020 to 28 Feb 2021.
- 22 Nov 2019 Planned primary completion date changed from 31 Oct 2020 to 16 Dec 2020.
- 23 Aug 2019 Planned End Date changed from 30 Oct 2020 to 31 Oct 2020.